tiprankstipranks
Glenmark Life Sciences Limited (IN:ALIVUS)
:ALIVUS
India Market
ALIVUS
Glenmark Life Sciences Limited
RESEARCH TOOLSreports
Want to see IN:ALIVUS full AI Analyst Report?

Glenmark Life Sciences Limited (ALIVUS) Income Statement

4 Followers

Glenmark Life Sciences Limited Income Statement

Last quarter (Q2 2025), Glenmark Life Sciences Limited's total revenue was ₹5.88B, an increase of 1.65% from the same quarter last year. In Q2, Glenmark Life Sciences Limited's net income was ₹1.30B. See Glenmark Life Sciences Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 22Mar 21Mar 19Mar 18
Total Revenue
₹ 23.72B₹ 21.23B₹ 18.85B₹ 14.05B₹ 2.48M
Gross Profit
₹ 7.64B₹ 10.80B₹ 9.80B₹ 7.79B₹ 110.00K
Operating Expenses
₹ 1.43B₹ 5.01B₹ 4.18B₹ 3.69B₹ 240.00K
Depreciation and Amortization
₹ 606.09M₹ 378.77M₹ 333.94M₹ 192.62M₹ 140.00K
EBITDA
₹ 7.17B₹ 6.31B₹ 5.92B₹ 2.48B₹ 10.00K
Operating Income
₹ 6.24B₹ 5.79B₹ 5.62B₹ 2.36B₹ -130.00K
Other Income/Expenses
₹ 303.35M₹ -2.59B₹ -2.84B₹ -54.36M₹ 0.00
Pretax Income
₹ 6.54B₹ 5.65B₹ 4.71B₹ 4.04B₹ -130.00K
Net Income
₹ 4.86B₹ 4.19B₹ 3.52B₹ 2.93B₹ -4.34M
Per Share Metrics
Basic EPS
₹ 39.63₹ 35.63₹ 32.61₹ 23.89₹ -0.04
Diluted EPS
₹ 39.52₹ 35.63₹ 32.61₹ 23.89₹ -0.04
Weighted Average Shares Outstanding
 122.54M 117.53M 107.80M 122.53M 107.80M
Weighted Average Shares Outstanding (Diluted)
 122.88M 117.53M 107.80M 122.53M 107.80M
Currency in INR

Glenmark Life Sciences Limited Earnings and Revenue History